Exosomal miRNAs as biomarkers in predicting chemotherapy-induced cardiotoxicity in patients with cancer (Review)

Vedant Shah1, Viraj Panchal2, Abhi Shah2

  • 1Department of Internal Medicine, The New York Medical College Graduate Medical Education Program at St. Mary's General Hospital and Saint Clare's Health, Denville, NJ 07834, USA.

Medicine International
|September 29, 2025
PubMed

Insights

Exosomal microRNAs (miRNAs) show promise for early detection of cancer therapy-related cardiotoxicity. These biomarkers can identify subclinical cardiac changes, enabling timely interventions and personalized cardioprotective strategies.

Area of Science:

  • Cardiology
  • Oncology
  • Biomarkers

Background:

  • Cancer therapies like targeted therapies and immune checkpoint inhibitors improve patient outcomes but increase cardiotoxicity risk.
  • Cardiotoxicity ranges from subclinical dysfunction to severe cardiomyopathy, necessitating early detection and prevention.
  • Traditional biomarkers like troponins indicate damage post-injury, limiting early intervention.

Purpose of the Study:

  • To review the role of exosomal microRNAs (miRNAs) as early diagnostic biomarkers for cardiotoxicity induced by chemotherapeutic agents.
  • To highlight the potential of exosomal miRNAs in enabling timely intervention and personalized cardioprotective strategies.
  • To discuss the therapeutic potential of exosomal miRNAs in modulating cardiotoxicity-related molecular pathways.

Main Methods:

  • Literature review focusing on exosomal microRNAs (miRNAs) and their association with chemotherapy-induced cardiotoxicity.
  • Analysis of studies investigating miRNAs as non-invasive biomarkers for myocardial stress and damage.
  • Exploration of miRNA regulatory mechanisms in cardiotoxicity.

Main Results:

  • Exosomal miRNAs are stable in biological fluids and can reflect early myocardial stress and damage.
  • miRNAs offer earlier detection of subclinical cardiac changes compared to traditional biomarkers.
  • Exosomal miRNAs possess diagnostic potential and therapeutic possibilities for cardiotoxicity.

Conclusions:

  • Exosomal miRNAs are promising non-invasive biomarkers for the early diagnosis of cardiotoxicity.
  • Understanding exosomal miRNA expression is crucial for developing personalized cardioprotective strategies.
  • Exosomal miRNAs can aid in minimizing cardiovascular complications during cancer therapy.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K